This 5 March 2020 video from the USA says about itself:
10 times Trump downplayed the coronavirus
Over the past month, President Trump has regularly sought to downplay the coronavirus threat with a mix of facts and false statements.
Translated from Dutch NOS radio today:
A German company that is trying hard to develop a vaccine for the coronavirus is said to have been approached by the United States government. The US Americans exclusively want to buy the rights to a vaccine and the German government is trying to prevent that, the German [right wing] newspaper Welt am Sonntag reports based on sources from government circles.
Trump is said to attempt to get the vaccine exclusively for the US, according to Welt am Sonntag sources. Scientists from the CureVac company from Tübingen are said to be enticed by US Americans with high financial offers.
If Donald Trump would really care about the lives of people in the USA threatened by the coronavirus, then. instead of spending taxpayers’ money on bribing German scientists or on a $1.5 trillion Big Banking bailout, he would have Medicare For All; like Bernie Sanders wants, but which Trump (and Biden) do not want. Making the coronavirus vaccine, when it will exist, free for everyone, inside and outside of the USA. Instead of using United States taxpayers’ dollars to get some US Big Pharma corporation a private monopoly of the vaccine; making it affordable only to United States rich people like Trump.
U.S. ‘TRIED TO GET ACCESS’ TO GERMAN VACCINE RESEARCH The Trump administration attempted to persuade a German firm developing a possible vaccine for the coronavirus to move its research work to the United States, raising fears in Berlin that President Donald Trump was trying to assure that any inoculation would be available first, and perhaps exclusively, in the United States. [New York Times]
The U.S. would be first to get a French drugmaker’s vaccine if it works, and France is not happy.
The US has declared a vaccine war on the world. Only Britain and the US are refusing to ‘pool’ research internationally in the hope of making money on a coronavirus vaccine — but their power to keep ‘intellectual property’ private is waning, writes PRABIR PURKAYASTHA.